BioPharma
Services
Precision NanoSystems’ BioPharma Services accelerates the development of mRNA-lipid nanoparticle (LNP) formulations to create genomic medicines by using NanoAssemblr® instruments, ionizable lipids and off-the-shelf reagents offering, end-to-end LNP Formulation Services and technology transfer of manufacturing processes for cGMP production.
BioPharma Services has broad technical expertise in payload design and lipid-based delivery systems, including lipid nanoparticle and lipopolymeric formulations, for a wide range of disease applications.
mRNA, siRNA, saRNA, Replicon RNA
pDNA, dsDNA
Small Molecule
Peptide
Virus
Lipid Nanoparticles
Liposomes
Polymer Nanoparticles
Emulsions
Exosomes
Vaccine Development
Oncology
Liver Delivery
Cardiovascular Disease
Lung Delivery
Publication - Abstract
May 31, 2019
Vaccine
Video
August 04, 2017
Poster
November 09, 2021
Publication - Summary
April 04, 2019
The Journal of Neuroscience
Publication - Summary
February 27, 2018
Cell Reports